Spontaneous seroclearance of hepatitis B seromarkers and subsequent risk of hepatocellular carcinoma
- 13 November 2013
- Vol. 63 (10), 1648-1657
- https://doi.org/10.1136/gutjnl-2013-305785
Abstract
The associations between long-term risk of hepatocellular carcinoma (HCC) and spontaneous seroclearance of HBV e antigen (HBeAg), HBV DNA and HBV surface antigen (HBsAg) have never been examined by a prospective study using serially measured seromarkers. This study aimed to assess the importance of spontaneous HBeAg, HBV DNA and HBsAg seroclearance in the prediction of HCC risk. This study included 2946 HBsAg seropositive individuals who were seronegative for antibodies against HCV and free of liver cirrhosis. Serial serum samples collected at study entry and follow-up health examinations were tested for HBeAg, HBV DNA and HBsAg. Cox proportional hazards models were used to calculate the HRs of developing HCC after seroclearance of HBV markers. The HR (95% CI) of developing HCC after seroclearance of HBeAg, HBV DNA and HBsAg during follow-up was 0.63 (0.38 to 1.05), 0.24 (0.11 to 0.57) and 0.18 (0.09 to 0.38), respectively, after adjustment for age, gender and serum level of alanine aminotransferase at study entry. High HBV DNA levels at the seroclearance of HBeAg (mean±SD, 4.35±1.64 log10 IU/mL) may explain the non-significant association between HBeAg seroclearance and HCC risk. Among HBeAg seronegative participants with detectable serum HBV DNA at study entry, the lifetime (30-75-years-old) cumulative incidence of HCC was 4.0%, 6.6% and 14.2%, respectively, for those with seroclearance of both HBV DNA and HBsAg, seroclearance of HBV DNA only, and seroclearance of neither. Spontaneous seroclearance of HBV DNA and HBsAg are important predictors of reduced HCC risk.Keywords
This publication has 38 references indexed in Scilit:
- High Hepatitis B Surface Antigen Levels Predict Insignificant Fibrosis in Hepatitis B e Antigen Positive Chronic Hepatitis BPLOS ONE, 2012
- Natural history of chronic hepatitis B: what exactly has REVEAL Revealed?Liver International, 2012
- Changes in Serum Levels of HBV DNA and Alanine Aminotransferase Determine Risk for Hepatocellular CarcinomaGastroenterology, 2011
- Chronic hepatitis B: Update 2009Journal of Hepatology, 2009
- Liver biopsy findings in chronic hepatitis BJournal of Hepatology, 2009
- Hepatitis B virus infectionThe Lancet, 2009
- Hepatitis B Virus InfectionThe New England Journal of Medicine, 2008
- Early hepatitis B virus DNA reduction in hepatitis B e antigen-positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovirJournal of Hepatology, 2008
- Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular CarcinomaJNCI Journal of the National Cancer Institute, 2008
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 updateHepatology International, 2008